Charter Oak Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Sell
2,331
-32
-1% -$20.5K 0.1% 68
2025
Q4
$1.6M Buy
2,363
+2
+0.1% +$1.36K 0.12% 58
2025
Q3
$1.51M Sell
2,361
-597
-20% -$362K 0.12% 62
2025
Q2
$1.59M Sell
2,958
-3
-0.1% -$1.44K 0.13% 56
2025
Q1
$1.24M Sell
2,961
-142
-5% -$61.7K 0.11% 60
2024
Q4
$1.28M Sell
3,103
-23
-0.7% -$10.1K 0.12% 60
2024
Q3
$1.58M Sell
3,126
-49
-2% -$23.8K 0.15% 53
2024
Q2
$1.55M Sell
3,175
-11
-0.3% -$5.52K 0.16% 48
2024
Q1
$1.72M Sell
3,186
-51
-2% -$27.9K 0.18% 44
2023
Q4
$1.8M Sell
3,237
-15
-0.5% -$7.04K 0.21% 40
2023
Q3
$1.42M Hold
3,252
0.19% 47
2023
Q2
$1.63M Sell
3,252
-46
-1% -$22K 0.21% 48
2023
Q1
$1.65M Sell
3,298
-63
-2% -$30.1K 0.23% 47
2022
Q4
$1.37M Buy
3,361
+76
+2% +$29.5K 0.21% 55
2022
Q3
$1.07M Sell
3,285
-2,909
-47% -$1.07M 0.17% 57
2022
Q2
$2.17M Sell
6,194
-5
-0.1% -$2.04K 0.3% 45
2022
Q1
$3.39M Sell
6,199
-27
-0.4% -$14.2K 0.41% 36
2021
Q4
$4.1M Buy
6,226
+622
+11% +$390K 0.48% 32
2021
Q3
$3.48M Sell
5,604
-45
-0.8% -$30.2K 0.44% 33
2021
Q2
$3.57M Sell
5,649
-135
-2% -$74.5K 0.46% 32
2021
Q1
$2.83M Sell
5,784
-3
-0.1% -$1.5K 0.4% 33
2020
Q4
$2.89M Buy
+5,787
New +$2.59M 0.44% 31

Other funds holding IDXX

Charter Oak Capital Management's IDXX Position: Q1 2026 in Review

Charter Oak Capital Management reduced its Idexx Laboratories (IDXX) stake by 1.4% in Q1 2026, selling an estimated $20.5K and leaving 2,331 shares worth $1.31M. The position accounts for 0.1% of the portfolio, ranked #68.

Charter Oak Capital Management first reported a position in IDXX in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.1M in Q4 2021. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Charter Oak Capital Management held 2,331 shares of Idexx Laboratories worth $1.31M as of Q1 2026.
  • Charter Oak Capital Management sold 32 Idexx Laboratories shares in Q1 2026, an estimated $20.5K.
  • Idexx Laboratories made up 0.1% of Charter Oak Capital Management's portfolio in Q1 2026, its #68 holding.
  • Charter Oak Capital Management first reported a position in Idexx Laboratories in Q4 2020 and has held it in 22 quarters since.
  • Charter Oak Capital Management's Idexx Laboratories position peaked at $4.1M in Q4 2021.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Charter Oak Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.